<?xml version="1.0" encoding="UTF-8"?>
<p>As of November 2019, the World Health Organization reported 2494 laboratory-confirmed cases of MERS-CoV infection in 27 countries with 858 deaths globally, resulting in an approximate 34% mortality rate [
 <xref rid="CIT0091" ref-type="bibr">91</xref>]. All known MERS-CoV infections can be traced to countries in the Middle East, primarily Saudi Arabia. Most cases have been in adults with underlying chronic diseases or immunosuppression who live or travel in the Arabian Peninsula. Among 1351 confirmed cases between 2012 and 2019, cases aged &lt;18 years were less than 5% of all confirmed cases [
 <xref rid="CIT0092" ref-type="bibr">92</xref>]. MERS-CoV infection in adults usually occurs as sporadic cases, healthcare-associated infection, or transmission within families [
 <xref rid="CIT0093" ref-type="bibr">93</xref>]. However, most confirmed pediatric cases were secondary cases after exposures to others within the same family [
 <xref rid="CIT0094" ref-type="bibr">94</xref>].
</p>
